FDA Letter API

ACH Group, LLC d/b/a Candy Co E-Liquids

Letter data

Company
ACH Group, LLC d/b/a Candy Co E-Liquids
Recipient
ACH Group, LLC d/b/a Candy Co E-Liquids | United States
Issue date
2018-07-13
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Tobacco
CMS ID
Not available
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER ACH Group, LLC d/b/a Candy Co E-Liquids July 13, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Tobacco Recipient: ACH Group, LLC d/b/a Candy Co E-Liquids United States Issuing Office: United States Center for Tobacco Products 10903 New Hampshire Avenue Silver Spring, MD 20993 July 13, 2018 VIA UPS and Electronic Mail Allen Park ACH Group, LLC d/b/a Candy Co E-Liquids 14946 Shoemaker Ave Ste A Santa Fe Springs, CA 90670 candycoeliquids@gmail.com sales@candycoeliquids.com RE: Warning Letter issued to ACH Group, LLC d/b/a Candy Co E-Liquids(RW1800852) Dear Allen Park: On May 1, 2018, the United States Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) issued you a Warning Letter informing you that your Patches by Candy Co e-liquid product is misbranded under section 903(a)(1) and/or 903(a)(7)(A) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because its labeling and/or advertising is false or misleading . Specifically, FDA determined that the labeling and/or advertising of your Patches by Candy Co e-liquid is misleading under section 903(a)(1) and/or 903(a)(7)(A) of the FD&C Act because it causes the product to imitate food products, particularly ones that are marketed toward, and/or appealing to, children. Based on our evaluation, it appears that you have taken steps to address the violation identified in the Warning Letter. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the FD&C Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Should you have any questions or concerns, please contact me at (301) 796-9235 or by email at elenita.ibarrapratt@fda.hhs.gov . Sincerely, /S/ Ele Ibarra-Pratt Division Director Office of Compliance and Enforcement Center for Tobacco Products VIA UPS and Electronic Mail cc: Allen Park ACH Group, LLC d/b/a Candy Co E-Liquids 10941 Hayford St Norwalk, CA  90650 GoDaddy.com, LLC abuse@godaddy.com Content current as of: 08/23/2018 Regulated Product(s) Tobacco